Abstract:Overexpression of human epidermal growth factor receptor (EGFR) plays an important role in several signaling pathways inside and outside the cell, especially in the processes of cell proliferation, differentiation, and death in various cancers. Due to the complexity of the structure and function of EGFR, research on the fluorescence visualization of EGFR protein visualization has proved challenging. One possible strategy for designing a receptor-targeting fluorescent probe with a switching mechanism is to introduce an environment-sensitive fluorophore into the drug ligand. Based on this strategic molecular design, we introduced two environment-sensitive small molecular fluorophores, dansyl chloride (DNS) and nitrobenzoxadiazole (NBD), to replace the morpholine group of gefitinib, achieving a series of fluorescent molecular probes bearing a switching mechanism. The GN probes exhibited prominent environment sensitivity, suggesting good performance as turn-on EGFR-targeting fluorescent ligands. The representative probe GN3 specifically responded to tumor cells overexpressing EGFR, which was validated with live-cell fluorescence imaging and in vivo xenograft tumor imaging. Ligand-induced EGFR phosphorylation in A431 cells was considerably inhibited by probe GN3, demonstrating that this probe still functions as an EGFR inhibitor. Owing to the turn-on response of GN3 to EGFR in tumor cells, and the competitive replacement behavior to the EGFR inhibitor gefitinib, these probes have the potential to be used for fluorescence imaging of cells overexpressing EGFR.

A Turn-On Supramolecular Fluorescent Probe for Sensing Lapatinib and Its Application in Living Cell Imaging

A Redox-Activated Pt(IV) Pro-Probe: from G-quadruplex Imaging to Cancer Therapy.

A Turn-on Supramolecular Fluorescent Probe for Sensing Benzimidazole Fungicides and Its Application in Living Cell Imaging

Lysosome-Specific Coumarin-Based Fluorescent Bioprobes for in Vivo Polarity Sensing and Cancer Treatment

A Novel Fluorescent Indicator Displacement Assay for Sensing the Anticancer Drug Gefitinib

Cetuximab-conjugated Iodine Doped Carbon Dots As a Dual Fluorescent/ct Probe for Targeted Imaging of Lung Cancer Cells.

Far-red/near-infrared Fluorescence Light-Up Probes for Specific in Vitro and in Vivo Imaging of a Tumour-Related Protein.

A Diketopyrrolopyrrole-Based Ratiometric Fluorescent Probe for Endogenous Leucine Aminopeptidase Detecting and Imaging with Specific Phototoxicity in Tumor Cells.

A Ratiometric Fluorescent Probe for Monitoring Leucine Aminopeptidase in Living Cells and Zebrafish Model.

A novel near-infrared EGFR targeting probe for metastatic lymph node imaging in preclinical mouse models

An intracellularly activatable, fluorogenic probe for cancer imaging.

A Novel BODIPY Quaternary Ammonium Salt-Based Fluorescent Probe: Synthesis, Physical Properties, and Live-Cell Imaging

A Near-Infrared Fluorescent Probe for Monitoring Leucine Aminopeptidase in Living Cells

Design of a Ph-Sensitive Supramolecular Fluorescent Probe for Selective Cancer Cell Imaging

Diketopyrrolopyrrole-based Fluorescence Probes for the Imaging of Lysosomal Zn2+ and Identification of Prostate Cancer in Human Tissue.

Supramolecular fluorescence sensor array used for the analysis of tyrosine kinase inhibitors in biological fluids and cell imaging

A turn-on fluorescence probe based on aggregation-induced emission for leucine aminopeptidase in living cells and tumor tissue.

A Novel Near-Infrared Fluorescent Light-Up Probe for Tumor Imaging and Drug-Induced Liver Injury Detection

γ-Glutamyl transpeptidase–activated indole-quinolinium based cyanine as a fluorescence turn-on nucleolus-targeting probe for cancer cell detection and inhibition

Conformationally Induced Off-On Cell Membrane Chemosensor Targeting Receptor Protein-Tyrosine Kinases for in Vivo and in Vitro Fluorescence Imaging of Cancers.

Discovery of EGFR-Targeted Environment-Sensitive fluorescent probes for cell imaging and efficient tumor detection